27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
McMillin Homes Constr., Inc. v. National Fire & Marine Ins. Co., 35 Cal.App.5th 1042 (2019); Fourth ...
Read More >
The US Department of Homeland Security (DHS) announced that it will no longer allow New York residen...
Read More >
In response to an amicus brief submitted by the Equal Employment Opportunity Commission (EEOC), the ...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
The shutdown of non-essential businesses and the social distancing measures employed to mitigate the...
Read More >
One of the most controversial taxes of the Affordable Care Act (ACA) is in danger of repeal. The tax...
Read More >